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BACKGROUND: The conceptualization of patient com-
plexity is just beginning in clinical medicine.
OBJECTIVES: This study aims (1) to propose a concep-
tual approach to complex patients; (2) to demonstrate
how this approach promotes achieving congruence
between patient and provider, a critical step in the
development of maximally effective treatment plans;
and (3) to examine availability of evidence to guide
trade-off decisions and assess healthcare quality for
complex patients.
METHODS/RESULTS: The Vector Model of Complexity
portrays interactions between biological, socioeconom-
ic, cultural, environmental and behavioral forces as
health determinants. These forces are not easily dis-
cerned but exert profound influences on processes and
outcomes of care for chronic medical conditions.
Achieving congruence between patient, physician, and
healthcare system is essential for effective, patient-
centered care; requires assessment of all axes of the
Vector Model; and, frequently, requires trade-off de-
cisions to develop a tailored treatment plan. Most
evidence-based guidelines rarely provide guidance for
trade-off decisions. Quality measures often exclude
complex patients and are not designed explicitly to
assess their overall healthcare.
CONCLUSIONS/RECOMMENDATIONS: We urgently
need to expand the evidence base to inform the care of
complex patients of all kinds, especially for the clinical
trade-off decisions that are central to tailoring care. We
offer long- and short-term strategies to begin to incor-
porate complexity into quality measurement and per-
formance profiling, guided by the Vector Model.
Interdisciplinary research should lay the foundation
for a deeper understanding of the multiple sources of
patient complexity and their interactions, and how
provision of healthcare should be harmonized with
complexity to optimize health.
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Vector Model of Complexity.
J Gen Intern Med 22(Suppl 3):382–90
DOI: 10.1007/s11606-007-0307-0
© Society of General Internal Medicine 2007
INTRODUCTION
Complex patients are increasingly common in clinical medi-
cine. Patients made complex by multiple cooccuring medical
conditions have been the focus of recent discussions, with
concerns expressed about potential vulnerability created by
the current approach to quality of care assessment and
accountability in health care.
1–4 However, socioeconomic,
cultural, behavioral, and environmental circumstances also
contribute to complexity, but these latter sources of complexity
and their ramifications have not received similar attention. In
fact, there is currently no widely accepted conceptualization
that portrays the numerous influences that together make a
patient more or less complex.
Patient complexity from any source may affect process or
outcomes of care, resulting in the need to adjust care plans.
Clinical guidelines have become essential tools for providing
evidence-based care, but few provide guidance for making
trade-off decisions, either to individual providers or to health
systems.
1,2 Furthermore, current quality measures do not
incorporate complexity,
3 and the recent trend toward tying
reimbursement to disease-specific quality measures may
increase attention to improving the measures at the possible
expense of patient-centered, individually tailored care.
2–4
In this paper, we propose the Vector Model of Complexity, a
conceptual model that defines complexity along axes repre-
senting major determinants of health. We demonstrate that the
patient’s complexity along numerous axes has profound
implications for the delivery of effective chronic health care.
We discuss how the Vector Model can be used to maximize the
impact of medical recommendations on health outcomes.
Then, we examine how well evidence-based tools help clini-
cians and health systems to accomplish this. Finally, we
propose strategies to integrate the Vector Model into the
process and assessment of healthcare delivery to maximize
the quality of chronic care for complex patients, a large and
growing number of Americans.
5
CONCEPTUAL FRAMEWORK OF PATIENT
COMPLEXITY
The American Heritage Dictionary defines “complex” as “consist-
ing of interconnected or interwoven parts; involved or intricate,
as in structure; complicated.” While all humans are inherently
complex, some patients are more challenging to care for than
others. What then makes some more complex than others?
JGIM
382In answer, consider first the determinants of health, which
includebiology/genetics,socioeconomics,culture,environment/
ecology, behavior, and the medical system.
6–10 Ac o m m o nm o d e l
is depicted in Figure 1.
The associations of each determinant with health outcomes
have been examined at the population level.
7,11,12 However, the
contribution from each determinant may vary in individual
patients, and the relationships between the domains of
determinants is not provided by the schematic diagram. The
overall effect of the various determinants is therefore unclear.
Furthermore, the model does not demonstrate how clinicians
or the healthcare system should modify their interactions with
patients, given the mix of determinants present, to optimize
the health of the patient.
To address these needs, we propose the Vector Model of
Complexity (Fig. 2), using the principles of vector physics.
Each health determinant from Figure 1 (except healthcare) is
conceptualized as exerting its influence along an axis, which
intersects with the other determinants’ axes at a central point,
the patient. Complexity can exist along each axis as a force
which has both magnitude and directionality, defining vector v.
At any given time, a particular vector may exert a force
increasing complexity, or alternatively, lessening complexity.
In vector physics, an overall vector can be summed together
(see also Appendix); in the Vector Model, we conceptualize
overall complexity as being similarly determined by multiple
components. While the summary vector in physics can be
precisely calculated, we do not know the mathematical
relationships between the vectors of patient complexity. Nev-
ertheless, the concept of a formal relationship among the
different domains of complexity is clinically useful: according
to the Vector Model of Complexity, two patients with similar
biologic complexity may present greater or less overall com-
plexity along any given axis, at a given encounter, depending
on the relative sum of vectors at that time (Fig. 2).
The Vector Model provides a basis from which to examine
how the sixth determinant of health, medical care, should be
adapted to maximize its impact on health. Clinicians focus
primarily on the biological axis consistent with the emphasis in
allopathic medical education on the biology of disease; how-
ever, influences along the other axes can either augment or
diminish complexity along the biological axis. This results in
similar treatment plans producing different results in patients
with differing complexity. Assessment of all the axes of
complexity may be an essential step in developing effective
treatment plans for individual patients.
The interrelatedness between the axes is a key feature of the
Vector Model, distinguishing it from previous conceptualiza-
tions of the determinants of health. The Vector Model explicitly
acknowledges that the determinants are related. For example,
recent immigrants may live in impoverished, environmentally
disadvantageous locations (such as inner city slums); to have
restricted financial means; and to lack health insurance.
Cultural influences may exert pressures toward tobacco use,
unhealthy diets, and mistrust in an unfamiliar approach to
medical care. Cultural complexity therefore influences socio-
economic, environmental, and behavioral complexity. To rep-
resent these relationships, we add a web to the intersecting
axes. The web has several appealing relevant features. Al-
though they are often difficult to discern, the strands connect
every aspect of the web, with each axis linked directly with all
others, so that when one part of the web is perturbed, the
entire web may be affected. The interconnections superficially
appear tenuous, but may in fact be quite tenacious (Fig. 2).
Table 1, organized by complexity vector, lists examples of
factors that contribute to complexity, leading to differential
effectiveness of medical treatment. Importantly, the Vector
Model allows an individual’s level of complexity to vary over
time, reflecting the dynamic nature of complexity. For example,
individuals newly diagnosed with diabetes must make consid-
erable efforts to modify diet and exercise, and to monitor blood
sugar. Once incorporated into the patient’s lifestyle, these
salutary health behaviors tend to diminish complexity at
future encounters. Each encounter with the healthcare system
can be thought of as a series of vector diagrams. Whether the
provider and healthcare system prove helpful or effective
depends upon both (1) the complete assessment of the
patient’s complexity, and (2) the provider and healthcare
system being equipped to respond.
The Vector Model in Action: Illustrative
Case Vignettes
To better illustrate how these influences interact in patients,
consider two illustrative cases (Fig. 3).
Mr. Smith has biological complexity, with multiple newly
recognized conditions. However, his personal, family, and
community circumstances exert stabilizing and supportive
forces along social, cultural and environmental axes, dimin-
ishing the overall complexity confronting his treating physi-
cians. Mr. Smith has the means to find culturally concordant
doctors whom he can trust, enhancing motivation to quit
smoking, make lifestyle changes, and take his medicines. His
overall complexity vector along the biological axis is low
(Fig. 4), and his treating physicians need not modify their
usual approach.
In contrast, Mr. Jones has similar biological forces, but his
other axes contribute forces toward greater complexity. Mr.
Jones’ social support is much less than Mr. Smith’s. He has
limited finances and may have difficulty paying for all the
recommended medications, new diet, and follow-up care. He
must balance his own self-care needs with his wife’s. His
environment makes it difficult to exercise, and an unsafe
neighborhood may contribute to stress. Mr. Jones’ overall
complexity is greater than Mr. Smith’s.
Without a very different approach by his treating physicians
than that used for Mr. Smith, Mr. Jones may conclude that his
doctors do not understand his situation, become over-
whelmed, and lose motivation to quit smoking and make
difficult lifestyle changes. The Vector Model of Complexity
therefore explains why a disease-focused approach (that is,
considering the biological vector alone) works well in Mr. Smith
but fails in Mr. Jones. Figure 1. Outcomes oriented model of the determinants of health
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Explanatory models of sickness, a medical anthropological
concept,
13 provide a mechanism to use the Vector Model to
create effective treatment plans. According to these explanato-
ry models, “physicians diagnose and treat diseases (abnormal-
ities in the structure and function of body organs and
systems), whereas patients suffer illnesses (experiences of
disvalued changes in states of being and in social function)”.
14
Explanatory models of sickness fit well into the Vector Model of
Complexity: they are determined by culture (national, racial,
ethnic, occupational, or professional), religious beliefs, educa-
tion and knowledge, social class [socioeconomic and cultural
vectors]; gender, age, and personality traits [biological and
behavioral vectors].
Hence, an important goal of the medical encounter is for the
doctor and patient to develop “congruence,” or, a shared view
of realistically attainable health care goals. The physician must
assess each axis of the Vector Model, harmonizing the
treatment plan accordingly. Congruence may enhance trust,
satisfaction, respect for preferences, adherence with recom-
mendations, salutary self-management behaviors, and mutu-
ality in the evaluation of treatment outcomes.
12–17 The
influence of trust and perceived discrimination on adherence
with treatment plans and with health outcomes supports the
importance of congruence.
11
The healthcare system must also be designed to promote
congruence. While some healthcare systems can provide
successful care to individuals with, for example, addiction,
homelessness, and culturally unique needs, others can be
distinctly unaccommodating for such patients.
Failure to achieve congruence between patient and provider
may provide insight into why half of patients with chronic
disease do not take medications as directed.
18 Noncongruence
may contribute to differential use of preventive services,
diagnostic procedures, and therapeutic interventions by
race/ethnicity, even when access to care, diagnosis, and
severity of illness are similar. In fact, patient “non-adherence,”
may be an excellent signal of (1) incomplete assessment of
complexity and failure to modify the clinical approach accord-
ingly, and/or (2) a healthcare system that remains ill-tooled to
address the needs of complex patients.
Table 1. Examples of Contributors to Differential Medical Treatment
Effects and of their Consequences, by Patient Complexity
Component Vector
Vector Sources of increased
complexity along the
Vector
Specific
consequence
Socioeconomics Lack of health
insurance
Difficulty affording
treatment
Lack of transportation Difficulty accessing
providers
Low educational
attainment
Inability to navigate
complex systems
Culture Race/ethnicity Care that is not
culturally sensitive
Language Communication
barriers
Communication Distrust, perceived
discrimination
Biology/
genetics
Multiple comorbidities Medication
interactions
Genetic variability Cannot achieve
recommended targets
Cognitive impairment Inability to follow
recommendations
Environment/
ecology
Pollution Exposure to toxins
Neighborhood violence Inability to exercise
Lack of public
transportation
Inability to buy
healthy foods
Behavior Smoking tobacco Cardiovascular,
pulmonary disease
Unhealthy diet Obesity
Lack of physical activity Diabetes
Figure 2. Interrelationships between influences on health that can lead to a complex patient: the Vector Model of Complexity. A patient’s
complexity arises from different axes, but physicians often focus on the biological axis (underlined). Each axis is related directly to the others,
represented by the strands of a web that link both neighboring axes and axes that are not depicted as direct neighbors. For simplicity, we
have shown only the strands between the biological axis and each of the others; in fact, we envision such strands to tie each axis to every
other. Both the angles between each axis and the others, and therefore their relative situation to the other axes, and the tenacity of the
strands tying the axes could be estimated through empiric work
384 Safford et al.: Vector Model of Complexity JGIMUnfortunately, physicians receive little training on how to
achieve congruence. While cultural competency is increasingly
being added to educational curricula, these programs have
unknown success.
19 In fact, it is not clear how each axis of the
Vector Model should be assessed, and validated instruments to
capture aspects of each axis are primarily designed for
research purposes. Evidence-based guidelines are a corner-
stone to guide clinical management; how well do they help
physicians care for complex patients?
GUIDANCE FOR IMPLEMENTING EVIDENCE-BASED
CARE FOR COMPLEX PATIENTS
Complex patients do benefit from evidence-based care. Al-
though relatively few in number, clinical trials conducted in
real-life settings demonstrated important clinical benefits
20–25;
a good example is the antihypertensive and lipid lowering to
prevent heart attack trial (ALLHAT). Effective interventions to
help individuals modify health-related behavior including
physical activity, diet, and smoking exist.
26,27 Likewise, trials
conducted in socioeconomically and culturally complex
patients suggest benefits, if individuals can be sufficiently
engaged to become active, motivated participants.
28–33 Even
individuals with complex environmental exposures, such as
inner city asthma patients, benefit from evidence-based
care.
29,30
Moreover, systems can be redesigned specifically to assure
that key healthcare processes are accomplished in complex
patients.
34 Specific system interventions with promising
results include colocation of services for persons with com-
bined substance abuse and medical illness
35,36;m e d i c a l
respite care as an adjunct to primary medical care for
homeless persons
37; and group visits for disadvantaged dia-
betic individuals.
38
While evidence-based care works in complex patients and
system redesign is possible, important gaps remain. The trade-
off decisions central to tailoring treatment plans should be
informed by answering questions such as: Does time to
achieve benefits differ across types of patients? Are some
Case 1. 
Mr. Smith is a 56 year old African American man recently discharged from the 
hospital after suffering a heart attack. He was given medications to control his 
blood pressure and lipids, and advised to take aspirin, as well as to quit smoking. 
While in the hospital, he was also diagnosed with diabetes, and given much 
information about changing his diet and exercising. He lives in a suburban 
neighborhood and has a stable employment situation with good health insurance 
benefits. He has a supportive wife and family. 
 
Case 2. 
Mr. Jones is a 56 year old European American man recently discharged from the 
hospital after suffering a heart attack. He was given medications to control his 
blood pressure and lipids, and advised to take aspirin, as well as to quit smoking. 
While in the hospital, he was also diagnosed with diabetes, and given much 
information about changing his diet and exercising. He lives in an inner city 
impoverished neighborhood with a sick wife who requires much care. He works as 
a truck driver, and has limited health insurance benefits.
Figure 3. Two patients with similar biologic but dissimilar socioeconomic, culture, environmental, and behavioral complexity
Figure 4. Complexity vectors for Mr. Smith and Mr. Jones. The arrows represent vector forces (V). In vector physics, these arrows can be
added in space (for more details, see Appendix), and we propose an analogous relationship between the various domains of health
determinants. The biological axis is a traditional focus, therefore it is dashed. Greater complexity along the biological axis is toward the top of
the diagram, lesser complexity toward the bottom. For both patients, the biological complexity vector (VBIO) has the same magnitude and
direction, but the other vectors differ markedly. The block arrows represent the summary vectors along the biological axis, which for Mr. Smith
indicate less overall complexity compared with the biological complexity vector alone (arrow points down). However, for Mr. Jones, the
summary vector indicates greater overall complexity compared with the biological complexity vector alone (arrow points up). BIOL
biological, SES socioeconomic, CUL cultural, ENV environmental, BEH behavioral
385 Safford et al.: Vector Model of Complexity JGIMindividuals more prone to treatment-induced harm than
others? How does overall risk/benefit assessment change with
complexity? What is the incremental benefit of achieving
progress toward an ideal risk factor level? What is the overall
health effect of multiple interventions implemented simulta-
neously? Does this differ as the number of medical conditions
rises? What is the relative effectiveness of different interven-
tions? Evidence syntheses, such as the CDC’s report on the
relative cost-effectiveness of hypertension, lipid and glycemic
control interventions in older type 2 diabetes patients are
helpful but rare.
39
Guidelines for Complex Patients
Currently available guidelines tend to focus on single diseases
and not on the needs of complex patients,
1–3 a striking finding
on perusal of the over 2,000 available guidelines on the Agency
for Healthcare Research and Quality’s National Guideline
Clearinghouse website.
40 Notable exceptions include the Veter-
ans Affairs/Department of Defense (VA/DoD) Diabetes Guide-
line (advising adjusting targets for glycemic control based on
life expectancy) and the California Healthcare Foundation/
American Geriatrics Society’s (CHF/AGS) diabetes guidelines
(1) (which advise prioritizing care among multiple conditions).
In fact, guidelines are almost invariably silent about clinical
trade-off decisions.
3 The CHF/AGS diabetes guidelines are a
notable exception in their recommendation to consider more
liberal glycemic control targets and greater focus on hyperten-
sion control in older diabetic patients.
1 However, more typical
is advice in the Expert Consensus Document on Beta-Adren-
ergic Receptor Blockers
41 for patients with chronic obstructive
pulmonary disease vis-à-vis beta blockers. Note is made that
such patients do benefit, but they should be “carefully
monitored” without further guidance on what type of monitor-
ing is recommended, or which specific characteristics identify
patients at particular risk.
Trade-off decisions arise along each axis of complexity. Even
when sociocultural issues are mentioned in guidelines, specific
recommendations for how to address them are uncommon.
For example, the Guideline for Family-Centered Care and the
Pediatrician’s Role recommends “honoring racial, ethnic, cul-
tural, and socioeconomic diversity and its effect on the family’s
experience and perception of care”, but offers no specific
advice.
40 Notable exceptions are the National Health Care for
the Homeless Council’s seven condition-specific guidelines and
one broader guideline for the primary care of homeless
individuals.
42,43
Left to themselves, patients make their own trade-off
decisions. Consider diabetes self-care. The American Diabetes
Association recommends 2 h of self-care tasks daily,
44 unreal-
istic for many people, especially for a truck driver like Mr.
Jones, who may routinely drive 10–11 h daily.
45 Community-
dwelling diabetic patients reported spending on average 1 h
daily on self-care.
46 However, diabetic women spent excess
time on foot care and too little on exercise, suggesting that
medical guidance on trade-off decisions may better optimize
health.
46 Diabetes guidelines offer no recommendations for
prioritizing patients’ self-care time.
44
Physicians, too, may make suboptimal trade-off decisions,
underutilizing some interventions in complex patients and
overusing others. Physicians of older women with chronic
stable angina who had 40% the mammography screening
rates of healthy women might have overestimated the influ-
ence of angina on life expectancy.
47 In contrast, up to one third
of men over 75 undergo potentially unneeded prostate cancer
screening; their life expectancy is limited.
48 Physicians prior-
itized glycemic control over blood pressure control in diabetic
patients,
49 despite evidence that aggressive blood pressure
control is cost-saving in older patients with type 2 diabetes and
tight glycemic control is far less cost-effective.
39 Physicians
may also contribute to lower rates of potentially beneficial
services among socioeconomically or culturally complex
patients.
50,51
Quality Measurement for Complex Patients
Given that evidence suggests suboptimal care, a systematic
approach to assessing the quality of care received by complex
patients is warranted. In fact, currently unmeasured aspects
of care may be especially relevant to complex patients. Efforts
to reflect a more global assessment of overall quality of care are
hampered by lack of consensus on important methodologic
issues, such as how to adjust for patients characteristics or
create summary measures. Patients themselves may be que-
ried, but cost and biases inherent in surveying patients are
considerable.
Quality measures tend to focus on single diseases without
differentiation for complex patients. The VA/DoD, whose
Diabetes Guidelines recognize complexity imposed by limited
life expectancy, has an opportunity to construct quality
measures based on life expectancy, alongside their current
age-limited performance measures. The VA has become a
widely recognized leader in quality and performance, thus
could play an important leadership role in incorporating
complexity into performance measures.
Because trade-off decisions are so central to the care of
complex patients, incorporating patients’ preferences becomes
essential for high quality care. For example, Mr. Jones and his
physician may liberalize some treatment goals to create a
realistic, achievable program of care. Quality metrics do not
currently include assessment of patient preferences, although
important work in this area has begun and validated scales
assess patient opinions about the success of various aspects of
the clinical encounter in meeting their personal needs.
52,53 We
echo others’ concerns that the Pay-for-Performance program
creates a possible disincentive to elicit patient preferences and
the development of an individualized care plan
2–4; if physician
income is tied to the proportion of patients with HbA1c<7%,
glycemic control targets may not be the result of shared
decision-making.
Patient complexity has been incorporated to some extent
into widely implemented reimbursement schemes, offering
potential lessons for quality measurement. The Diagnosis
Related Group system reimburses more for hospital stays for
complicated patients based on the presence of comorbid
conditions or complications. Similarly, outpatient visit reim-
bursement for Medicare patients is tied to the level of visit
complexity, based on the number of a defined set of elements
addressed, illness severity, and amount of time spent. Note
that nonbiological complexity is only indirectly incorporated in
the time component of this scheme.
While overcoming many of these challenges requires long-
term investment, several possible short-term approaches
using available methods are worth noting. Stratifying mea-
386 Safford et al.: Vector Model of Complexity JGIMsures on life expectancy, using well-established methods,
54–57
could include many older patients currently excluded from
quality assessment. Peer-based benchmarking is another well-
developed approach that could be more widely applied, and
inherently accounts for complexity.
58 Peer-based benchmark-
ing compares the performance of an individual to their peer
group using sound statistical methods. The lack of evidence on
what is realistically achievable is an uncomfortable undercur-
rent in the quality industry, which often sets benchmarks by
expert opinion in the absence of empiric evidence.
59 The extent
to which low performance among even the best performing
clinicians is driven by patient complexity is an empirical
question worth examining.
IMPLICATIONS FOR PRACTICE, POLICY,
AND RESEARCH
1. Practice implications: Evidence and guidelines. Most press-
ingly, we need studies that provide data for clinical trade-
off decisions: on the relative effectiveness of interventions
within and across diseases, by increments of disease
control, and more “real world” effectiveness studies such
as the ALLHAT. More evidence synthesis studies that can
model time to benefit and relative benefits
39 are also
essential. New evidence and evidence syntheses should
be incorporated into guidelines, using the Vector Model of
Complexity as a framework. Disease-specific guidelines
could consider how complexity along each of the Vector
Model’s axes might change recommendations, with guid-
ance for trade-off decisions. General guidelines for the care
of complex patients with advice on how to assess and
address each axis of the Vector Model are also needed.
2. Policy implications: Incorporate complexity into quality mea-
surement and performance profiling. Strategies discussed
above that could be implemented in the short term include
stratifying quality measures on life expectancy,
54–57 with
new quality measures for individuals with decreased life
expectancy, and wider implementation of peer bench-
marking as an alternative to arbitrary benchmarks. In
the longer term, a more comprehensive assessment of
quality of care for complex patients along multiple axes is
needed. Specific strategies for how to create metrics to
assess the care of complex patients are important areas for
future work, for which the Vector Model can serve as a
conceptual framework.
3. Research implications: Multidisciplinary teams, standards
for clinical trials. The assessment of nonbiological axes, the
relative contribution of each axis to overall complexity, and
the interrelatedness of each complexity vector require
multiple scientific perspectives and methodologies, as
emphasized in the current NIH roadmap.
Sociologists, education theorists, complexity scientists, and
experts in neural networks are some of the potential team
members who might work alongside physicians and biostatis-
ticians to carry out multidisciplinary studies on patient
complexity in healthcare. This research should first develop
validated methods for quantifying patient complexity along
each axis, empirically determining appropriate weighting of the
relative contribution of each axis. This may be followed by the
development of complexity metrics for quality assessment, and
include patient preferences in the metrics. New standards for
clinical trials could mandate the reporting of incremental
benefits and quality of life outcomes, providing a long-term
solution for theknowledge gap that currentlyhampersevidence-
based trade-off decision-making.
CONCLUSION
Patients may exhibit complexity along any of several axes of
the Vector Model of Complexity, which are interrelated in
subtle ways. If the multiple forces of complexity are not
recognized and addressed, they become barriers to reaching
congruence between patient and provider, leading to nonad-
herence, and diminishing the physician’s effectiveness on
optimizing health. A rigid, unaccommodating healthcare sys-
tem can further prevent the achievement of congruence.
Achieving congruence requires trade-off decisions, yet there is
a distressing paucity of empiric evidence to guide such
decisions. Trade-off decisions are largely ignored by current
evidence-based guidelines and quality measurement systems.
We urgently need to expand the evidence base to inform
clinical trade-off decisions, and interdisciplinary teams need
to develop methods to measure patient complexity and to
integrate such measurement into guidelines and quality
assessment. Our Vector Model offers a framework for this
future work.
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APPENDIX
Summing vectors
Vectors can be summed in space as follows. Consider 3 vectors
VBIOL,V CUL, and VSES as shown.
VBIOL
   VCUL
       VSES
387 Safford et al.: Vector Model of Complexity JGIMWe start with the 2 vectors VCUL and VSES. In order to sum
them, we construct a parallelogram and determine its long
axis.
VBIOL 
VCUL 
VSES 
VSES + CUL
In order to find the sum of all 3 vectors, we construct
another parallelogram using VSES + CUL and VBIOL.
VBIOL 
VSES + CUL 
VSES + CUL + BIOL
RELATIVE SUMMATION OF VECTORS TO OBTAIN
THE TOTAL COMPLEXITY ALONG ANY AXIS
For a given health care practitioner, the focus of care is along
primarily one axis. For physicians, that is usually the biolog-
ical axis. The question for the physician is: how does complex-
ity along the other axes influence the patient’s biological
management at this encounter?
This question can be answered by determining the compo-
nent of a given vector along the biological axis. In the example
above, let us first determine the component of the cultural
vector that contributes complexity to the biological axis.
BIOL
VCUL
The relative contribution of VCUL along the biological axis is
evaluated by dropping a perpendicular line from the end of
VCUL onto the biological axis. This component of VCUL can be
thought of as (VCUL) BIOL
          VCUL
(VCUL) BIOL 
BIOL 
To find the total effect on complexity along the biological
axis, the (VCUL) BIOL can be added to the biological complexity
vector as follows:
CUL) BIOL 
VCOMPLEXITY  BIOL
BIOL  
In this example, the total complexity along the biological
axis [(VCOMPLEXITY) BIOL=VBIOL +( V CUL) BIOL] is made greater by
cultural complexity. Cultural concordance and high levels of
trust can create a vector along the cultural axis that
diminishes biological complexity. The direction of the cultural
vector will be negative, and the summary force of complexity
along the biological axis will be diminished compared to the
biological vector alone.
VCUL  (VCUL) BIOL 
 BIOL 
(VCUL) BIOL 
(VCOMPLEXITY) BIOL
VBIOL 
This same procedure can be repeated for each of the vectors
present along any axis to arrive at a complexity vector that
reflects the effect on the biological complexity vector of all
present complexity vectors.
Note that this principle of summation can be applied to any
axis. A behavioral scientist will likely be interested in total
complexity along the behavioral axis, an anthropologist in the
total complexity along the cultural axis, etc.
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